The enteral feeding devices market is likely to expand its roots at an average CAGR of 4.0% during the forecast period. The market is anticipated to hold a share of US$ 2.8 billion in 2023 while it is anticipated to cross a value of US$ 4.1 billion by 2033.
The research report on the enteral feeding devices market explains that the expanding healthcare services along with increasing intensive care units and proficient dialysis systems are gaining traction in the market. The proliferation of private healthcare systems along with the advent of home-based enteral feeding devices are likely to expand the enteral feeding devices market size. Patients with organ failure that go through dialysis procedures require regular nutrient-feeding demand for enteral feeding devices. Enteral feeding pumps are used as an alternative to gravity and syringe methods of feeding to deliver enteral nutrition. Pumps can be used to administer bolus and intermittent feeds, as well as for continuous feeding. An increase in accidents is another reason why victims end up in temporary and permanent conditions where enteral feeding devices are the only option through which nutritional supplements can be fed.
The enteral feeding devices market outlook states that emerging economies such as India and China are building and restructuring their healthcare systems. In the process, the authorities are adopting the latest equipment and technology to counter any serious health crisis. Thus, higher adoption of enteral feeding devices is expected during the forecast period. Advanced feeding pumps and enteral feeding tubes make up the applications of NICUs and ICUs. Furthermore, the small healthcare spaces that cover a locality have also started offering feeding support to critical patients. Therefore, as the demand for critical care equipment rises, the enteral feeding devices market is likely to expand its boundaries in the potential marketplaces.
| Attributes | Details |
|---|---|
| Enteral Feeding Devices Market CAGR (2023 to 2033) | 4.0% |
| Enteral Feeding Devices Market Size (2023) | US$ 2.8 billion |
| Enteral Feeding Devices Market Size (2033) | US$ 4.1 billion |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Short-term Growth: From 2017 to 2022, the global enteral feeding devices market registered a CAGR of 4.6%. The enteral feeding devices market held nearly 20.0% of the overall gastrointestinal device market, which is, valued at US$ 12.5 billion in 2021.
Patients with low voluntary intake, persistent neurological or mechanical dysphagia, or gut malfunction, as well as those who are severely sick, benefit greatly from enteral feeding devices.
Many patients who formerly required parenteral nutrition can now be administered successfully with enteral nutrition alone or in conjunction with parenteral nutrition. The surging gastrointestinal access methods, better delivery systems, and breakthroughs in enteral feeding formulae are driving the demand for enteral feeding devices.
Mid-term Growth: The enteral feeding devices market is shifting away from hospital-based care towards home-based enteral nutrition (HEN). Because of escalating hospital expenditures, clinicians treating patients who require long-term nutritional care are increasingly turning to HEN. Patients with certain chronic diseases are not required to be admitted to hospitals for enteral feeding treatments. Various solutions, such as portable feeding pumps and ready-to-use enteral feeding supplies, are commercially available. Medical service providers offer services related to enteral feeding at home.
Long-term Growth: Increasing adoption of enteral feeding in-home care settings and an increase in people suffering from chronic illnesses are two utmost drivers driving the enteral feeding devices market forward.
In addition, the advancements in healthcare diagnostic and treatment techniques have led to the provision of improved patient care by providing personalized solutions. Thereby, increasing the life expectancy for patients suffering from several chronic and other serious conditions. However, the market flourishes at a comparatively lower CAGR of 4.0% between 2023 and 2033.
In the coming years, the Asia Pacific region is likely to provide substantial development possibilities for market competitors. This is related to the region's diverse healthcare markets, the rising incidence of infectious and chronic diseases, and growing research and development activities to produce breakthrough medical technology.
Furthermore, infrastructure advances in healthcare facilities, rising healthcare spending, and growing low-cost manufacturing advantage in the region are projected to encourage market players to invest in the area in the coming years.
Gastrostomy buttons are low-profile gastrostomy devices that are growing in favor among G-tube users. Gastrostomy devices are especially well suited for children and active adults since the buttons are flush with the skin rather than protruding as a tube away from the body.
Despite the growing popularity of enteral feeding devices, currently, acceptable techniques include utilizing a surgical G-tube or PEG device to introduce a patient's initial G-tube. The patient's tube can be replaced with a button device once the stoma has recovered. These advances are resulting in increased consumer satisfaction, which is creating an array of opportunities for the enteral feeding devices market ahead.
Companies interested in capitalizing on this growing market segment should start by developing a low-profile product for patient usage. Several companies, like Boston Scientific and Halyard Health, have already made the switch to one-step insertion kits for their button devices.
Principal Consultant
Physicians and key industry leaders indicated that an overall lack of patient education is negatively influencing the enteral feeding devices market. Many patients prefer to forego and effectively rule out enteral feeding as an option in some cases. Patients also lack an understanding of the benefits of prophylactic EN.
Lack of consumer awareness for procedures using enteral feeding devices limits the market space. Companies are trying to initiate legit campaigns to promote the use of enteral feeding devices.
Reimbursement can be a limiting factor affecting patients’ enteral feeding market growth. In developed nations such as the United States, Canada, Germany, France, the United Kingdom, and Japan, enteral nutrition treatment is covered by insurance. In underdeveloped nations spanning Asia Pacific, Latin America, and the Middle East, however, reimbursements for enteral feeding are minimal.
This provides a substantial hurdle to the broad adoption of enteral feeding. Furthermore, reduced government funding, high cost, and related reimbursement cuts for home healthcare services are likely to add to the issues encountered by enteral feeding device manufacturers in the forecast period.
| Regions | Absolute Market Growth |
|---|---|
| United States | US$ 364.8 million |
| United Kingdom | US$ 57.0 million |
| China | US$ 187.7 million |
| Japan | US$ 148.5 million |
| South Korea | US$ 50.1 million |
Strong Healthcare Systems along with Higher Investments for Enteral Feeding Systems post-pandemic is Propelling the Market Growth
| Region | Attributes |
|---|---|
| United States Market CAGR (2023 to 2033) | 4.1% |
| United States Market Absolute Doller Growth (US$ million/billion) | US$ 364.8 million |
As per FMI, sales in the United States enteral feeding devices market are expected to lead the market at a 4.1% CAGR over the forecast period, reaching a valuation of US$ 1.1 billion in 2033.
The key driving factors behind the growth of the enteral feeding devices market include a rise in the incidence of chronic ailments, high acceptance of enteral feeding devices in home care settings, the availability of numerous well-equipped hospitals, as well as the steady transition from parenteral to enteral nutrition devices.
According to the latest data provided by the American Cancer Society, there were about 26,380 new cases of stomach cancer in the United States in 2022. (15,900 in men and 10,480 in women) This kind of cancer resulted in the deaths of around 11,090 people (6,690 men and 4,400 women). Since patients with stomach cancer require enteral nutrition, data show that demand for enteral feeding systems is expected to rise soon
Emerging Economies like China and India increase their Critical Care Spending to Restructure the Healthcare Systems
| Region | Attributes |
|---|---|
| Chinese Market CAGR (2023 to 2033) | 4.9% |
| Chinese Market Absolute Doller Growth (US$ million/billion) | US$ 187.7 million |
In 2021, China held a share of 46.8% in the East Asia enteral feeding devices market and is projected to expand at a CAGR of 4.9% from 2023 to 2033. The growing awareness of the usage of enteral feeding devices, effective reimbursement policies, and a rise in the necessity for reconstructive surgery and radiation procedures are just a few of the causes driving up regional demand. The market is expected to cross a value of US$ 495.3 million by 2033.
Moreover, key players in this market are focusing on launching theologically advanced products, which is contributing to the growth of enteral feeding device production and its usage.
Advanced Pumping Technology with Efficient and Easy Home-based Systems is gaining Traction in the Regional Market
| Region | Attributes |
|---|---|
| Japanese Market CAGR (2023 to 2033) | 4.4% |
| Japanese Market Absolute Doller Growth (US$ million/billion) | US$ 148.5 million |
The Japanese market is anticipated to have a significant share in the market over the forecast period, with sales growing at an average of 4.4% CAGR between 2023 and 2033. Total demand in the market is forecast to reach a valuation of US$ 422.4 million by 2033, offering an absolute dollar opportunity of US$ 148.5 million over the forecast period.
With Japan being the epicenter of technological implementations, it also contributes its share in the healthcare sector. Japanese physicians have researched the effects of enteral feeding solutions for pediatric Crohn's disease. The results came positive and hence it is recommended for the same in the region. This is likely to fuel the sales of enteral feeding devices in the region.
India held an 81.3% share in the South Asia enteral feeding devices market in 2021 and is projected to increase at a significant CAGR rate during the forecast period because of increased affordability, increased healthcare spending, and increased awareness of safe enteral feeding goods.
In addition, the count of premature babies is increasing across the country. Premature births and their consequences are the most common cause of infant death.
According to the most recent data from Newborn & Child Health and the World Health Organization, India ranks first among the ten countries that contribute 60% of the world's premature births, with 3,519,100 preterm births, or over 24% of the total number.
Prematurely born babies endure long-term health issues such as cerebral palsy, poor growth, and starvation. These negative events, together with an increase in chronic diseases, are expected to increase the use of enteral feeding devices in the country.
Germany is set to exhibit a significant CAGR in the European enteral feeding devices market during the forecast period. The increasing number of patients suffering from cancer, the growing geriatric population, the rising prevalence of neurological diseases, and increasing surgical procedures are likely to boost demand for enteral feeding devices to meet their nutritional needs.
Additionally, early approval of enteral feeding devices and the high adoption of enteral feeding pumps in this region is boosting the market growth.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
| Segment | Top Product Type |
|---|---|
| Top Sub-segment | Enteral Feeding Pumps |
| CAGR (2017 to 2022) | 4.8% |
| CAGR (2023 to 2033) | 5.2% |
| Segment | Top End User |
|---|---|
| Top Sub-segment | Hospital |
| CAGR (2017 to 2022) | 3.9% |
| CAGR (2023 to 2033) | 3.4% |
Enteral feeding pumps are used as an alternative to gravity and syringe methods of feeding to deliver enteral nutrition across pediatric and adult populations diagnosed with chronic diseases to enhance nutritional intake and prevent malnutrition, adoption of enteral feeding pumps is significant in this population base which presents significant growth opportunities.
Furthermore, an increase in the usage of the feeding pumps and lesser side effects as compared to other devices makes this segment thrive at a CAGR of 5.2% between 2023 and 2033 in the global enteral feeding devices market.
Hospitals lead the enteral feeding devices market with a CAGR of 3.4% during the forecast period. The high availability of enteral feeding systems in hospitals contributes to the high utilization rate of these devices.
Furthermore, hospitals' strong financial capabilities for acquiring high-priced enteral feeding equipment such as enteral pumps, the huge patient pool treated at hospitals, and the accessibility of trained professionals to operate enteral feeding devices all contribute to the segment’s growth.
Leading players in the enteral feeding devices market are focusing on geographical expansion to gain high revenue & expand their sales footprint in emerging countries through different strategies.
Capacity expansion and adoption of new technology-based products are the key strategies adopted by manufacturers to increase the sale in different geographies
Additionally, manufacturers are focusing on forwarding integration with partnerships with wholesalers, distributors, and other channel partners to gain ownership over the value chain.
Recent Market Developments
Mixers and Mix-in Blenders
China, Japan, and India are the key Asian countries in the enteral feeding devices market.
The current market valuation of the enteral feeding devices market is estimated to be US$ 2.8 billion in 2023.
The increasing use of minimally invasive procedures to insert enteral feeding tubes and the development of new materials for enteral feeding tubes that are more comfortable and less likely to cause complications.
Abbott Nutrition, ALCOR Scientific, Applied Medical Technology, B. Braun Melsungen AG, Boston Scientific, CONMED Corporation, Cook Medical, Cardinal Health, Inc., and Becton.
1. Executive Summary | Enteral Feeding Devices Marke
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Product Life Cycle Analysis
3.5. Supply Chain Analysis
3.5.1. Supply Side Participants and their Roles
3.5.1.1. Producers
3.5.1.2. Mid-Level Participants (Traders/ Agents/ Brokers)
3.5.1.3. Wholesalers and Distributors
3.5.2. Value Added and Value Created at Node in the Supply Chain
3.5.3. List of Raw Material Suppliers
3.5.4. List of Existing and Potential Buyer’s
3.6. Investment Feasibility Matrix
3.7. Value Chain Analysis
3.7.1. Profit Margin Analysis
3.7.2. Wholesalers and Distributors
3.7.3. Retailers
3.8. PESTLE and Porter’s Analysis
3.9. Regulatory Landscape
3.9.1. By Key Regions
3.9.2. By Key Countries
3.10. Regional Parent Market Outlook
3.11. Production and Consumption Statistics
3.12. Import and Export Statistics
4. Global Market Analysis 2017 to 2022 and Forecast, 2023 to 2033
4.1. Historical Market Size Value (US$ Million) & Volume (Units) Analysis, 2017 to 2022
4.2. Current and Future Market Size Value (US$ Million) & Volume (Units) Projections, 2023 to 2033
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Product Type
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Product Type, 2017 to 2022
5.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Product Type, 2023 to 2033
5.3.1. Enteral Feeding Pumps
5.3.2. PEGJ Tubes
5.3.3. Low-profile Tubes
5.3.3.1. Low-profile Balloon Tubes
5.3.3.2. Low-profile Non-Balloon Tubes
5.3.4. PEG Kit
5.3.4.1. PEG Balloon Kit
5.3.4.2. PEG Non-Balloon Kit
5.3.5. Replacement G-Tubes
5.3.5.1. Replacement Balloon G-Tubes
5.3.5.2. Replacement Non-Balloon G-Tubes
5.3.6. Nasojejunal Tubes
5.3.7. Nasogastric Tubes
5.4. Y-o-Y Growth Trend Analysis By Product Type, 2017 to 2022
5.5. Absolute $ Opportunity Analysis By Product Type, 2023 to 2033
6. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Age Group
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Age Group, 2017 to 2022
6.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Age Group, 2023 to 2033
6.3.1. Adult
6.3.2. Pediatric
6.4. Y-o-Y Growth Trend Analysis By Age Group, 2017 to 2022
6.5. Absolute $ Opportunity Analysis By Age Group, 2023 to 2033
7. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By End User
7.1. Introduction / Key Findings
7.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By End User, 2017 to 2022
7.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By End User, 2023 to 2033
7.3.1. Hospital
7.3.2. Clinic
7.3.3. Ambulatory Surgical Center
7.3.4. Home Care Setting
7.4. Y-o-Y Growth Trend Analysis By End User, 2017 to 2022
7.5. Absolute $ Opportunity Analysis By End User, 2023 to 2033
8. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Region
8.1. Introduction
8.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Region, 2017 to 2022
8.3. Current Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Region, 2023 to 2033
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. East Asia
8.3.5. South Asia
8.3.6. Oceania
8.3.7. Middle East and Africa
8.4. Market Attractiveness Analysis By Region
9. North America Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country
9.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2017 to 2022
9.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
9.2.1. By Country
9.2.1.1. USA
9.2.1.2. Canada
9.2.2. By Product Type
9.2.3. By Age Group
9.2.4. By End User
9.3. Market Attractiveness Analysis
9.3.1. By Country
9.3.2. By Product Type
9.3.3. By Age Group
9.3.4. By End User
9.4. Key Takeaways
10. Latin America Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country
10.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2017 to 2022
10.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
10.2.1. By Country
10.2.1.1. Brazil
10.2.1.2. Mexico
10.2.1.3. Argentina
10.2.1.4. Rest of Latin America
10.2.2. By Product Type
10.2.3. By Age Group
10.2.4. By End User
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Product Type
10.3.3. By Age Group
10.3.4. By End User
10.4. Key Takeaways
11. Europe Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country
11.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2017 to 2022
11.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
11.2.1. By Country
11.2.1.1. Germany
11.2.1.2. Italy
11.2.1.3. France
11.2.1.4. United Kingdom
11.2.1.5. Spain
11.2.1.6. BENELUX
11.2.1.7. Russia
11.2.1.8. Poland
11.2.1.9. Rest of Europe
11.2.2. By Product Type
11.2.3. By Age Group
11.2.4. By End User
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Product Type
11.3.3. By Age Group
11.3.4. By End User
11.4. Key Takeaways
12. East Asia Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country
12.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2017 to 2022
12.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
12.2.1. By Country
12.2.1.1. China
12.2.1.2. Japan
12.2.1.3. South Korea
12.2.2. By Product Type
12.2.3. By Age Group
12.2.4. By End User
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Product Type
12.3.3. By Age Group
12.3.4. By End User
12.4. Key Takeaways
13. South Asia Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country
13.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2017 to 2022
13.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
13.2.1. By Country
13.2.1.1. India
13.2.1.2. Thailand
13.2.1.3. Indonesia
13.2.1.4. Malaysia
13.2.1.5. Rest of South Asia
13.2.2. By Product Type
13.2.3. By Age Group
13.2.4. By End User
13.3. Market Attractiveness Analysis
13.3.1. By Country
13.3.2. By Product Type
13.3.3. By Age Group
13.3.4. By End User
13.4. Key Takeaways
14. Oceania Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country
14.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2017 to 2022
14.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
14.2.1. By Country
14.2.1.1. Australia
14.2.1.2. New Zealand
14.2.2. By Product Type
14.2.3. By Age Group
14.2.4. By End User
14.3. Market Attractiveness Analysis
14.3.1. By Country
14.3.2. By Product Type
14.3.3. By Age Group
14.3.4. By End User
14.4. Key Takeaways
15. Middle East and Africa Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country
15.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2017 to 2022
15.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
15.2.1. By Country
15.2.1.1. GCC Countries
15.2.1.2. South Africa
15.2.1.3. Rest of Middle East and Africa
15.2.2. By Product Type
15.2.3. By Age Group
15.2.4. By End User
15.3. Market Attractiveness Analysis
15.3.1. By Country
15.3.2. By Product Type
15.3.3. By Age Group
15.3.4. By End User
15.4. Key Takeaways
16. Key Countries Market Analysis
16.1. USA
16.1.1. Pricing Analysis
16.1.2. Market Share Analysis, 2022
16.1.2.1. By Product Type
16.1.2.2. By Age Group
16.1.2.3. By End User
16.2. Canada
16.2.1. Pricing Analysis
16.2.2. Market Share Analysis, 2022
16.2.2.1. By Product Type
16.2.2.2. By Age Group
16.2.2.3. By End User
16.3. Brazil
16.3.1. Pricing Analysis
16.3.2. Market Share Analysis, 2022
16.3.2.1. By Product Type
16.3.2.2. By Age Group
16.3.2.3. By End User
16.4. Mexico
16.4.1. Pricing Analysis
16.4.2. Market Share Analysis, 2022
16.4.2.1. By Product Type
16.4.2.2. By Age Group
16.4.2.3. By End User
16.5. Argentina
16.5.1. Pricing Analysis
16.5.2. Market Share Analysis, 2022
16.5.2.1. By Product Type
16.5.2.2. By Age Group
16.5.2.3. By End User
16.6. Germany
16.6.1. Pricing Analysis
16.6.2. Market Share Analysis, 2022
16.6.2.1. By Product Type
16.6.2.2. By Age Group
16.6.2.3. By End User
16.7. Italy
16.7.1. Pricing Analysis
16.7.2. Market Share Analysis, 2022
16.7.2.1. By Product Type
16.7.2.2. By Age Group
16.7.2.3. By End User
16.8. France
16.8.1. Pricing Analysis
16.8.2. Market Share Analysis, 2022
16.8.2.1. By Product Type
16.8.2.2. By Age Group
16.8.2.3. By End User
16.9. United Kingdom
16.9.1. Pricing Analysis
16.9.2. Market Share Analysis, 2022
16.9.2.1. By Product Type
16.9.2.2. By Age Group
16.9.2.3. By End User
16.10. Spain
16.10.1. Pricing Analysis
16.10.2. Market Share Analysis, 2022
16.10.2.1. By Product Type
16.10.2.2. By Age Group
16.10.2.3. By End User
16.11. BENELUX
16.11.1. Pricing Analysis
16.11.2. Market Share Analysis, 2022
16.11.2.1. By Product Type
16.11.2.2. By Age Group
16.11.2.3. By End User
16.12. Russia
16.12.1. Pricing Analysis
16.12.2. Market Share Analysis, 2022
16.12.2.1. By Product Type
16.12.2.2. By Age Group
16.12.2.3. By End User
16.13. Poland
16.13.1. Pricing Analysis
16.13.2. Market Share Analysis, 2022
16.13.2.1. By Product Type
16.13.2.2. By Age Group
16.13.2.3. By End User
16.14. China
16.14.1. Pricing Analysis
16.14.2. Market Share Analysis, 2022
16.14.2.1. By Product Type
16.14.2.2. By Age Group
16.14.2.3. By End User
16.15. Japan
16.15.1. Pricing Analysis
16.15.2. Market Share Analysis, 2022
16.15.2.1. By Product Type
16.15.2.2. By Age Group
16.15.2.3. By End User
16.16. South Korea
16.16.1. Pricing Analysis
16.16.2. Market Share Analysis, 2022
16.16.2.1. By Product Type
16.16.2.2. By Age Group
16.16.2.3. By End User
16.17. India
16.17.1. Pricing Analysis
16.17.2. Market Share Analysis, 2022
16.17.2.1. By Product Type
16.17.2.2. By Age Group
16.17.2.3. By End User
16.18. Thailand
16.18.1. Pricing Analysis
16.18.2. Market Share Analysis, 2022
16.18.2.1. By Product Type
16.18.2.2. By Age Group
16.18.2.3. By End User
16.19. Indonesia
16.19.1. Pricing Analysis
16.19.2. Market Share Analysis, 2022
16.19.2.1. By Product Type
16.19.2.2. By Age Group
16.19.2.3. By End User
16.20. Malaysia
16.20.1. Pricing Analysis
16.20.2. Market Share Analysis, 2022
16.20.2.1. By Product Type
16.20.2.2. By Age Group
16.20.2.3. By End User
16.21. Australia
16.21.1. Pricing Analysis
16.21.2. Market Share Analysis, 2022
16.21.2.1. By Product Type
16.21.2.2. By Age Group
16.21.2.3. By End User
16.22. New Zealand
16.22.1. Pricing Analysis
16.22.2. Market Share Analysis, 2022
16.22.2.1. By Product Type
16.22.2.2. By Age Group
16.22.2.3. By End User
16.23. GCC Countries
16.23.1. Pricing Analysis
16.23.2. Market Share Analysis, 2022
16.23.2.1. By Product Type
16.23.2.2. By Age Group
16.23.2.3. By End User
16.24. South Africa
16.24.1. Pricing Analysis
16.24.2. Market Share Analysis, 2022
16.24.2.1. By Product Type
16.24.2.2. By Age Group
16.24.2.3. By End User
17. Market Structure Analysis
17.1. Competition Dashboard
17.2. Competition Benchmarking
17.3. Market Share Analysis of Top Players
17.3.1. By Regional
17.3.2. By Product Type
17.3.3. By Age Group
17.3.4. By End User
18. Competition Analysis
18.1. Competition Deep Dive
18.1.1. Abbott Nutrition
18.1.1.1. Overview
18.1.1.2. Product Portfolio
18.1.1.3. Profitability by Market Segments
18.1.1.4. Sales Footprint
18.1.1.5. Strategy Overview
18.1.1.5.1. Marketing Strategy
18.1.1.5.2. Product Strategy
18.1.1.5.3. Channel Strategy
18.1.2. ALCOR Scientific
18.1.2.1. Overview
18.1.2.2. Product Portfolio
18.1.2.3. Profitability by Market Segments
18.1.2.4. Sales Footprint
18.1.2.5. Strategy Overview
18.1.2.5.1. Marketing Strategy
18.1.2.5.2. Product Strategy
18.1.2.5.3. Channel Strategy
18.1.3. Applied Medical Technology
18.1.3.1. Overview
18.1.3.2. Product Portfolio
18.1.3.3. Profitability by Market Segments
18.1.3.4. Sales Footprint
18.1.3.5. Strategy Overview
18.1.3.5.1. Marketing Strategy
18.1.3.5.2. Product Strategy
18.1.3.5.3. Channel Strategy
18.1.4. B. Braun Melsungen AG
18.1.4.1. Overview
18.1.4.2. Product Portfolio
18.1.4.3. Profitability by Market Segments
18.1.4.4. Sales Footprint
18.1.4.5. Strategy Overview
18.1.4.5.1. Marketing Strategy
18.1.4.5.2. Product Strategy
18.1.4.5.3. Channel Strategy
18.1.5. Boston Scientific
18.1.5.1. Overview
18.1.5.2. Product Portfolio
18.1.5.3. Profitability by Market Segments
18.1.5.4. Sales Footprint
18.1.5.5. Strategy Overview
18.1.5.5.1. Marketing Strategy
18.1.5.5.2. Product Strategy
18.1.5.5.3. Channel Strategy
18.1.6. CONMED Corporation
18.1.6.1. Overview
18.1.6.2. Product Portfolio
18.1.6.3. Profitability by Market Segments
18.1.6.4. Sales Footprint
18.1.6.5. Strategy Overview
18.1.6.5.1. Marketing Strategy
18.1.6.5.2. Product Strategy
18.1.6.5.3. Channel Strategy
18.1.7. Cook Medical
18.1.7.1. Overview
18.1.7.2. Product Portfolio
18.1.7.3. Profitability by Market Segments
18.1.7.4. Sales Footprint
18.1.7.5. Strategy Overview
18.1.7.5.1. Marketing Strategy
18.1.7.5.2. Product Strategy
18.1.7.5.3. Channel Strategy
18.1.8. Cardinal Health, Inc.
18.1.8.1. Overview
18.1.8.2. Product Portfolio
18.1.8.3. Profitability by Market Segments
18.1.8.4. Sales Footprint
18.1.8.5. Strategy Overview
18.1.8.5.1. Marketing Strategy
18.1.8.5.2. Product Strategy
18.1.8.5.3. Channel Strategy
18.1.9. Becton, Dickinson and Company
18.1.9.1. Overview
18.1.9.2. Product Portfolio
18.1.9.3. Profitability by Market Segments
18.1.9.4. Sales Footprint
18.1.9.5. Strategy Overview
18.1.9.5.1. Marketing Strategy
18.1.9.5.2. Product Strategy
18.1.9.5.3. Channel Strategy
18.1.10. Fresenius Kabi
18.1.10.1. Overview
18.1.10.2. Product Portfolio
18.1.10.3. Profitability by Market Segments
18.1.10.4. Sales Footprint
18.1.10.5. Strategy Overview
18.1.10.5.1. Marketing Strategy
18.1.10.5.2. Product Strategy
18.1.10.5.3. Channel Strategy
18.1.11. Owens & Minor, Inc.
18.1.11.1. Overview
18.1.11.2. Product Portfolio
18.1.11.3. Profitability by Market Segments
18.1.11.4. Sales Footprint
18.1.11.5. Strategy Overview
18.1.11.5.1. Marketing Strategy
18.1.11.5.2. Product Strategy
18.1.11.5.3. Channel Strategy
18.1.12. Medline
18.1.12.1. Overview
18.1.12.2. Product Portfolio
18.1.12.3. Profitability by Market Segments
18.1.12.4. Sales Footprint
18.1.12.5. Strategy Overview
18.1.12.5.1. Marketing Strategy
18.1.12.5.2. Product Strategy
18.1.12.5.3. Channel Strategy
18.1.13. Moog
18.1.13.1. Overview
18.1.13.2. Product Portfolio
18.1.13.3. Profitability by Market Segments
18.1.13.4. Sales Footprint
18.1.13.5. Strategy Overview
18.1.13.5.1. Marketing Strategy
18.1.13.5.2. Product Strategy
18.1.13.5.3. Channel Strategy
18.1.14. Nestlé Health Science
18.1.14.1. Overview
18.1.14.2. Product Portfolio
18.1.14.3. Profitability by Market Segments
18.1.14.4. Sales Footprint
18.1.14.5. Strategy Overview
18.1.14.5.1. Marketing Strategy
18.1.14.5.2. Product Strategy
18.1.14.5.3. Channel Strategy
18.1.15. Danone SA
18.1.15.1. Overview
18.1.15.2. Product Portfolio
18.1.15.3. Profitability by Market Segments
18.1.15.4. Sales Footprint
18.1.15.5. Strategy Overview
18.1.15.5.1. Marketing Strategy
18.1.15.5.2. Product Strategy
18.1.15.5.3. Channel Strategy
18.1.16. Vygon SA
18.1.16.1. Overview
18.1.16.2. Product Portfolio
18.1.16.3. Profitability by Market Segments
18.1.16.4. Sales Footprint
18.1.16.5. Strategy Overview
18.1.16.5.1. Marketing Strategy
18.1.16.5.2. Product Strategy
18.1.16.5.3. Channel Strategy
18.1.17. Amsino International, Inc.
18.1.17.1. Overview
18.1.17.2. Product Portfolio
18.1.17.3. Profitability by Market Segments
18.1.17.4. Sales Footprint
18.1.17.5. Strategy Overview
18.1.17.5.1. Marketing Strategy
18.1.17.5.2. Product Strategy
18.1.17.5.3. Channel Strategy
18.1.18. Fuji Systems Corp
18.1.18.1. Overview
18.1.18.2. Product Portfolio
18.1.18.3. Profitability by Market Segments
18.1.18.4. Sales Footprint
18.1.18.5. Strategy Overview
18.1.18.5.1. Marketing Strategy
18.1.18.5.2. Product Strategy
18.1.18.5.3. Channel Strategy
18.1.19. Neomed
18.1.19.1. Overview
18.1.19.2. Product Portfolio
18.1.19.3. Profitability by Market Segments
18.1.19.4. Sales Footprint
18.1.19.5. Strategy Overview
18.1.19.5.1. Marketing Strategy
18.1.19.5.2. Product Strategy
18.1.19.5.3. Channel Strategy
18.1.20. Smiths Medical
18.1.20.1. Overview
18.1.20.2. Product Portfolio
18.1.20.3. Profitability by Market Segments
18.1.20.4. Sales Footprint
18.1.20.5. Strategy Overview
18.1.20.5.1. Marketing Strategy
18.1.20.5.2. Product Strategy
18.1.20.5.3. Channel Strategy
19. Assumptions & Acronyms Used
20. Research Methodology
Explore Healthcare Insights
View Reports
Enteral Feeding Devices Market
